Fangfang Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Signaling Pathways in Disease 2
- Microbial Metabolic Engineering and Bioproduction 2
- Ubiquitin and proteasome pathways 1
-
- Bone Tissue Engineering Materials 2
- Biofuel production and bioconversion 2
- Co-authors
- Qiufei Xie (2 shared papers)Liang‐Hong Guo (1 shared paper)Limin Dong (2 shared papers)Wenqian Huang (1 shared paper)Monika Mortimer (1 shared paper)Juan Wang (1 shared paper)Wenjie Wei (1 shared paper)Lin Zhang (1 shared paper)
- Journals
- International Journal of Molecular Sciences (2 papers)Bio-Medical Materials and Engineering (1 paper)Polymer Chemistry (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Electronics (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fangfang Li
23 papers receiving 405 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 50
- Biomaterials 37
- Oral Surgery 15
- Molecular Biology 157
- Biomedical Engineering 97
Countries citing papers authored by Fangfang Li
This map shows the geographic impact of Fangfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Li more than expected).
Fields of papers citing papers by Fangfang Li
This network shows the impact of papers produced by Fangfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Li. The network helps show where Fangfang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangfang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 49 | |
| 2 | 2018 | 48 | |
| 3 | 2013 | 44 | |
| 4 | 2019 | 43 | |
| 5 | 2020 | 41 | |
| 6 | 2016 | 22 | |
| 7 | 2020 | 19 | |
| 8 | 2015 | 18 | |
| 9 | 2019 | 18 | |
| 10 | 2014 | 16 | |
| 11 | 2018 | 15 | |
| 12 | 2014 | 13 | |
| 13 | 2020 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 10 | |
| 16 | 2019 | 8 | |
| 17 | 2021 | 5 | |
| 18 | 2024 | 5 | |
| 19 | [Identification of dominant and fragrance-enhancing microorganisms of tobacco leaves during ripening]. | 2009 | 5 |
| 20 | 2024 | 3 |
About Fangfang Li
Fangfang Li is a scholar working on Molecular Biology, Biomedical Engineering, Cancer Research, Organic Chemistry and Surgery, having authored 25 papers that have together received 407 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Signaling Pathways in Disease (2 papers), Bone Tissue Engineering Materials (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers), Biofuel production and bioconversion (2 papers), Ubiquitin and proteasome pathways (1 paper), Renal cell carcinoma treatment (1 paper) and Photodynamic Therapy Research Studies (1 paper). The work is most often cited by research in Cancer Research (50 citations), Biomaterials (37 citations), Oral Surgery (15 citations), Molecular Biology (157 citations) and Biomedical Engineering (97 citations). Fangfang Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qiufei Xie, Liang‐Hong Guo, Limin Dong, Wenqian Huang, Monika Mortimer, Juan Wang, Wenjie Wei, Lin Zhang, Ying Liu and Xia Deng. Their work appears in journals such as International Journal of Molecular Sciences, Bio-Medical Materials and Engineering, Polymer Chemistry, Naunyn-Schmiedeberg s Archives of Pharmacology and Electronics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.